Hormone assay to assist heart failure assessment?
This article was originally published in Clinica
It might be possible to use measurement of serum concentrations of brain natriuretic peptide to guide the treatment of heart failure patients in a way analogous to the use of glycated haemoglobin in the management of diabetes.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.